Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Smith+Nephew Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map

globenewswire.com
SNN The article discusses Smith+Nephew's digital transformation strategy, innovation programs, and technology initiatives. It provides an overview of their business units and product portfolios, but does not offer a clear positive or negative outlook on the company's stock performance.

Smith+Nephew Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Smith+Nephew - 2025" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into the company's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its investments and its acquisitions.

Smith+Nephew is a UK-based medical technology company offering a wide range of medical devices to patients in more than 100 countries across the world.

The company operates through three global business units: Orthopaedics, Sports Medicine & Ear, Nose and Throat (ENT) and Advanced Wound Management (AWM). The Orthopaedics business division offers hip and knee implants for replacing worn, damaged, or diseased joints; robotics-assisted and enabling technologies; and services for surgeons.

This division also offers trauma products for stabilizing severe fractures and correcting bone deformities. Smith+Nephew's Sports Medicine portfolio comprises implants, technology, and instruments that facilitate minimally invasive surgical procedures. The company's ENT portfolio includes products for tonsil and adenoid removal, tympanostomy, sinus surgery, turbinate reduction, septoplasty, laryngeal and soft palate reduction, and epistaxis. Its AWM product portfolio includes products for treating chronic and acute wounds, such as diabetic and pressure ulcers, leg wounds, post-operative wounds, and burns.

The report provides information and insights into Smith+Nephew's tech activities, including:

Reasons to Buy

Key Topics Covered:

Companies Featured

For more information about this company profile visit https://www.researchandmarkets.com/r/5tzc5q

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.